Pulmonx CorporationPulmonx CorporationPulmonx Corporation

Pulmonx Corporation

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪306.64 M‬USD
−1.54USD
‪−60.84 M‬USD
‪68.68 M‬USD
‪35.12 M‬
Beta (1Y)
1.35

About Pulmonx Corporation

CEO
Steven S. Williamson
Headquarters
Redwood City
Employees (FY)
279
Founded
1995
FIGI
BBG000LZVJC9
Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LUNG is 8.08 USD — it has increased by 2.28% in the past 24 hours. Watch Pulmonx Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Pulmonx Corporation stocks are traded under the ticker LUNG.
LUNG stock has risen by 25.47% compared to the previous week, the month change is a 39.79% rise, over the last year Pulmonx Corporation has showed a 39.48% decrease.
We've gathered analysts' opinions on Pulmonx Corporation future price: according to them, LUNG price has a max estimate of 17.00 USD and a min estimate of 12.00 USD. Watch LUNG chart and read a more detailed Pulmonx Corporation stock forecast: see what analysts think of Pulmonx Corporation and suggest that you do with its stocks.
LUNG reached its all-time high on Dec 31, 2020 with the price of 69.48 USD, and its all-time low was 4.07 USD and was reached on Nov 4, 2022. View more price dynamics on LUNG chart.
See other stocks reaching their highest and lowest prices.
LUNG stock is 5.97% volatile and has beta coefficient of 1.35. Track Pulmonx Corporation stock price on the chart and check out the list of the most volatile stocks — is Pulmonx Corporation there?
Today Pulmonx Corporation has the market capitalization of ‪306.65 M‬, it has decreased by 2.16% over the last week.
Yes, you can track Pulmonx Corporation financials in yearly and quarterly reports right on TradingView.
Pulmonx Corporation is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
LUNG earnings for the last quarter are −0.36 USD per share, whereas the estimation was −0.47 USD resulting in a 23.33% surprise. The estimated earnings for the next quarter are −0.42 USD per share. See more details about Pulmonx Corporation earnings.
Pulmonx Corporation revenue for the last quarter amounts to ‪18.85 M‬ USD, despite the estimated figure of ‪18.03 M‬ USD. In the next quarter, revenue is expected to reach ‪20.15 M‬ USD.
LUNG net income for the last quarter is ‪−13.75 M‬ USD, while the quarter before that showed ‪−13.89 M‬ USD of net income which accounts for 1.00% change. Track more Pulmonx Corporation financial stats to get the full picture.
No, LUNG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 18, 2024, the company has 279.00 employees. See our rating of the largest employees — is Pulmonx Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pulmonx Corporation EBITDA is ‪−57.67 M‬ USD, and current EBITDA margin is −87.35%. See more stats in Pulmonx Corporation financial statements.
Like other stocks, LUNG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pulmonx Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pulmonx Corporation technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pulmonx Corporation stock shows the sell signal. See more of Pulmonx Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.